@dmdwarrior.com on Bluesky

Post

DMD WarrioR

dmdwarrior.com

did:plc:tmvk4z66cvoiuhshm46kb4jf

GNR-097: Duchenne Gene Therapy Phase 1/2 Study Started by Generium Generium is a Russian innovative biotechnology company has received approval to conduct a clinical trial of GNR-097 gene therapy drug for the treatment of progressive Duchenne muscular dystrophy (DMD). 👉 Read More: DMDWarrioR.com

2025-09-07T10:47:14.203Z

Enable JavaScript to use Bluesky.

Learn more about Bluesky at bsky.social and atproto.com.